HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

B O Boehm Selected Research

Glucose (Dextrose)

3/2009The L162V polymorphism of the peroxisome proliferator activated receptor alpha gene (PPARA) is not associated with type 2 diabetes, BMI or body fat composition.
6/2007The HMG-CoA reductase inhibitor cerivastatin lowers advanced glycation end products in patients with type 2 diabetes.
11/2004The PlA1/A2 polymorphism of platelet glycoprotein IIIa is not associated with the risk of type 2 diabetes. The Ludwigshafen Risk and Cardiovascular Health study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


B O Boehm Research Topics

Disease

9Type 1 Diabetes Mellitus (Autoimmune Diabetes)
02/2013 - 10/2000
8Type 2 Diabetes Mellitus (MODY)
01/2017 - 02/2001
5Diabetic Retinopathy (Retinopathy, Diabetic)
08/2004 - 02/2000
3Insulin Resistance
03/2009 - 09/2004
2Cardiovascular Diseases (Cardiovascular Disease)
11/2011 - 01/2009
2Neoplasms (Cancer)
09/2011 - 08/2000
2Coronary Artery Disease (Coronary Atherosclerosis)
07/2005 - 01/2001
2Myocardial Infarction
07/2005 - 11/2004
2Obesity
09/2004 - 02/2001
2Metabolic Bone Diseases (Osteopenia)
03/2003 - 02/2000
1Non-alcoholic Fatty Liver Disease
06/2015
1Inflammation (Inflammations)
01/2015
1Atherosclerotic Plaque (Atheroma)
01/2015
1Bone Fractures (Bone Fracture)
03/2014
1Ketosis
02/2013
1Cardiac Sudden Death (Sudden Cardiac Arrest)
01/2013
1Vascular Diseases (Vascular Disease)
01/2013
1Atherosclerosis
11/2011
1Peripheral Vascular Diseases (Peripheral Vascular Disease)
09/2011
1Carotid Stenosis (Carotid Artery Stenosis)
09/2011
1Stroke (Strokes)
09/2011
1Chronic Disease (Chronic Diseases)
11/2010
1Hypothyroidism
07/2010
1Thyroid Diseases (Thyroid Disease)
07/2010
1Insulinoma
07/2010
1Chronic Hepatitis B
02/2010
1Infections
02/2010
1Disease Susceptibility (Diathesis)
02/2009
1Coronary Disease (Coronary Heart Disease)
02/2008
1Hyperlipoproteinemias
06/2007
1Hyperglycemia
06/2007
1Glucose Intolerance
06/2007
1Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease)
11/2004
1Graves Disease (Basedow Disease)
09/2004
1Autoimmune Diseases (Autoimmune Disease)
09/2004
1Thyroiditis
09/2004
1Crohn Disease (Crohn's Disease)
03/2003
1Osteoporosis
03/2003
1Postmenopausal Osteoporosis
03/2003
1Dyslipidemias (Dyslipidemia)
01/2003

Drug/Important Bio-Agent (IBA)

5Insulin-Like Growth Factor I (IGF-1)IBA
12/2001 - 02/2000
4AntigensIBA
01/2017 - 10/2000
4Insulin (Novolin)FDA Link
02/2013 - 05/2002
4LipidsIBA
03/2009 - 02/2001
3Glutamate Decarboxylase (Decarboxylase, Glutamate)IBA
01/2017 - 05/2001
3HLA-DR Antigens (HLA-DR)IBA
07/2010 - 10/2000
3Glucose (Dextrose)FDA LinkGeneric
03/2009 - 11/2004
3Advanced Glycation End ProductsIBA
06/2007 - 08/2004
21-Alkyl-2-acetylglycerophosphocholine Esterase (PAF Acetylhydrolase)IBA
01/2015 - 01/2009
2AutoantibodiesIBA
02/2013 - 07/2010
2AntibodiesIBA
07/2010 - 09/2004
2Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
06/2007 - 01/2003
2N(6)-carboxymethyllysine (carboxymethyllysine)IBA
11/2004 - 08/2004
2CytokinesIBA
03/2004 - 04/2001
2pigment epithelium-derived factorIBA
06/2003 - 03/2003
2Biomarkers (Surrogate Marker)IBA
01/2001 - 02/2000
2Insulin-Like Growth Factor Binding ProteinsIBA
02/2000 - 02/2000
1Triglycerides (Triacylglycerol)IBA
06/2015
1Alanine Transaminase (SGPT)IBA
06/2015
1Hydrocortisone (Cortisol)FDA LinkGeneric
06/2015
1C-Reactive ProteinIBA
01/2015
125-hydroxyvitamin DIBA
03/2014
1Uric Acid (Urate)IBA
01/2013
1SelectinsIBA
11/2011
1AldosteroneIBA
11/2011
1Estradiol (Delestrogen)FDA LinkGeneric
09/2011
1SteroidsIBA
11/2010
1Transaminases (Aminotransferases)IBA
02/2010
1PPAR alphaIBA
03/2009
1Factor XII (Hageman Factor)IBA
02/2008
1HLA Antigens (Human Leukocyte Antigens)IBA
08/2007
1cerivastatin (Kazak)FDA Link
06/2007
1oxidized low density lipoproteinIBA
06/2007
1Insulin Glargine (Lantus)FDA Link
10/2005
1Isophane Insulin (NPH Insulin)FDA Link
10/2005
1Integrin alpha ChainsIBA
07/2005
1human platelet antigen 1bIBA
07/2005
1Platelet Membrane Glycoprotein IIbIBA
07/2005
1Integrin alpha2beta1IBA
07/2005
1IntegrinsIBA
07/2005
1C-PeptideIBA
11/2004
1Integrin beta3 (GPIIIa)IBA
11/2004
1Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA
09/2004
1Immunoglobulins (Immunoglobulin)IBA
09/2004
1ChemokinesIBA
09/2004
1Thyrotropin Receptors (Thyrotropin Receptor)IBA
09/2004
1HLA-DRB1*04 antigenIBA
03/2004
1preproinsulinIBA
03/2004
1AutoantigensIBA
03/2004
1Ibandronic Acid (Boniva)FDA Link
03/2003
1Sodium Fluoride (Ossin)FDA Link
03/2003
1Cholecalciferol (Vitamin D3)FDA Link
03/2003
1CalciumIBA
03/2003
1Vitamin DFDA LinkGeneric
03/2003
1Calcium CitrateIBA
03/2003
1insulin aspart protamine drug combination 30:70 insulin aspartIBA
05/2002
1Insulin Aspart (NovoLog)FDA Link
05/2002

Therapy/Procedure

1Nephrectomy
02/2010
1Therapeutics
03/2003
1Injections
05/2002